Prevalence and significance of MEFV gene mutations in a cohort of patients with rheumatoid arthritis

Joint Bone Spine

Volumn 77, Issue 1, 2010, Pages 32-35

  Koca, Suleyman Serdar ^a   Etem, Ebru Onalan ^a   Isik, Bahar ^b   Yuce, Huseyin ^a   Ozgen, Metin ^a   Dag, Muhammet Sait ^a   Isik, Ahmet ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

Familial Mediterranean fever; MEFV gene mutations; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; GENOMIC DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MEDITERRANEAN FEVER GENE; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; COHORT STUDIES; CYTOSKELETAL PROTEINS; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MUTATION; PEPTIDES, CYCLIC; SEVERITY OF ILLNESS INDEX; TURKEY; WRIST JOINT;

EID: 73449102470     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.08.006     Document Type: Article

References (40)

1. Klareskog L., Catrina A.I., and Paget S. Rheumatoid arthritis. Lancet 373 (2009) 659-672
2. Migita K., Nakamura T., Maeda Y., et al. MEFV mutations in Japanese rheumatoid arthritis patients. Clin Exp Rheumatol 26 (2008) 1091-1094
3. Rabinovich E., Livneh A., Langevitz P., et al. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 64 (2005) 1009-1014
4. Touitou I., Ben-Chetrit E., Notarnicola C., et al. Familial Mediterranean fever clinical and genetic features in druzes and in Iraqi jews: a preliminary study. J Rhumatol 25 (1998) 916-919
5. Chen X., Fischel-Ghodsian N., Cercek A., et al. Assessment of Pyrin gene mutations in Turks with familial Mediterranean fever (FMF). Hum Mutat 11 (1998) 456-460
6. Onen F., Sumer H., Turkay S., et al. Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin Exp Rheumatol 22 (2004) S31-S33
7. Cobankara V., Fidan G., Türk T., et al. The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 22 (2004) S27-S30
8. Yigit S., Bagci H., Ozkaya O., et al. MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience. J Rheumatol 35 (2008) 106-113 [corrected]
9. Yilmaz E., Ozen S., Balci B., et al. Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9 (2001) 553-555
10. Lachmann H.J., Sengül B., Yavuzşen T.U., et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45 (2006) 746-750
11. Tunca M., Akar S., Hawkins P.N., et al. The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. Eur J Hum Genet 10 (2002) 786-789
12. Pras E., Aksentijevich I., Gruberg L., et al. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 326 (1992) 1509-1513
13. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 17 (1997) 25-31
14. Papin S., Cuenin S., Agostini L., et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 14 (2007) 1457-1466
15. Schwartz T., Langevitz P., Zemer D., et al. Behçet's disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29 (2000) 286-295
16. Touitou I., Magne X., Molinari N., et al. MEFV Mutations in Behçet's disease. Hum Mutat 16 (2000) 271-272
17. Imirzalioglu N., Dursun A., Tastan B., et al. MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rheumatol 34 (2005) 56-58
18. Ozen S., Bakkaloglu A., Yilmaz, et al. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation?. J Rheumatol 30 (2003) 2014-2018
19. Cañete J.D., Arostegui J.I., Queiró R., et al. An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism. Arthritis Rheum 56 (2007) 2784-2788
20. Durmus D., Alayli G., Cengiz K., et al. Clinical significance of MEFV mutations in ankylosing spondylitis. Joint Bone Spine 76 (2009) 260-264
21. Cattan D., Notarnicola C., Molinari N., et al. Inflammatory bowel disease in non-Ashkenazi Jews with Familial Mediterranean fever. Lancet 355 (2000) 378-379
22. Akman-Demir G., Gul A., Gurol E., et al. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?. J Neurol 253 (2006) 928-934
23. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
24. Leeb B.F., Andel I., Sautner J., et al. Disease activity measurement of rheumatoid arthritis: Comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine. Arthritis Rheum 53 (2005) 56-60
25. Zangger P., Kachura J.R., Bombardier C., et al. Assessing damage in individual joints in rheumatoid arthritis: a new method based on the Larsen system. Joint Bone Spine 71 (2004) 389-396
26. Eisenberg S., Aksentijevich I., Deng Z., et al. Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med 129 (1998) 539-542
27. Medlej-Hashim M., Rawashdeh M., Chouery E., et al. Genetic screening of fourteen MUtations in Jordanian Familial Mediterranean Fever patients. Hum Mutat 15 (2000) 384
28. Stehlik C., and Reed J.C. The PYRIN connection: novel players in innate immunity and inflammation. J Exp Med 200 (2004) 551-558
29. Hawkins P.N., Gillmore J.D., Booth S.E., et al. Pyrin E148Q is prevalent globally and may upregulate the inflammatory response non-specifically. Abstracts of the familial Mediterranean fever II international conference, 3-7 May 2000, Antalya, Turkey. Clin Exp Rheumatol 18 (2000) A-4
30. Tunca M., Kirkali G., Soyturk M., et al. Acute phase response and evolution of Familial Mediterranean fever. Lancet 353 (1999) 1415
31. Tunca M., Akar S., Onen F., et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84 (2005) 1-11
32. Centola M., Wood G., Frucht D.M., et al. The gene for familial Mediterranean fever. MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 95 (2000) 3223-3231
33. Diaz A., Hu C., Kastner D.L., et al. Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever. Arthritis Rheum 50 (2004) 3679-3689
34. Pope R.M. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2 (2002) 527-535
35. McInnes I.B., and Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7 (2007) 429-442
36. Musabak U., Sengul A., Oktenli C., et al. Does immune activation continue during an attack-free period in familial Mediterranean fever?. Clin Exp Immunol 138 (2004) 526-533
37. Kinikli G., Bektas M., Misirlioglu M., et al. Relationship between HLA-DR. HLA-DQ alleles and MEFV gene mutations in familial Mediterranean fever (FMF) patients. Turk J Gastroenterol 16 (2005) 143-146
38. Zsilák S., Gál J., Hodinka L., et al. HLA-DR genotypes in familial rheumatoid arthritis: increased frequency of protective and neutral alleles in a multicase family. J Rheumatol 32 (2005) 2299-2302
39. Kacar C., Gilgil E., Tuncer T., et al. Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 24 (2005) 212-214
40. Koca S.S., Akbulut H., Dag S., et al. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis and Behçet's disease. Tohoku J Exp Med 213 (2007) 297-304